North America DNases, Ligases, and RNA Polymerases Market Size, Share & Trends Analysis Report By DNases Application, By Ligases Application (Oligonucleotide Synthesis and Others), By RNA Polymerases Application, By Country and Growth Forecast, 2024 - 203

North America DNases, Ligases, and RNA Polymerases Market Size, Share & Trends Analysis Report By DNases Application, By Ligases Application (Oligonucleotide Synthesis and Others), By RNA Polymerases Application, By Country and Growth Forecast, 2024 - 2031


The North America DNases, Ligases, And RNA Polymerases Market would witness market growth of 9.8% CAGR during the forecast period (2024-2031).

The US market dominated the North America DNases, Ligases, And RNA Polymerases Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $410.3 Million by 2031. The Canada market is experiencing a CAGR of 12.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 11.2% during (2024 - 2031).

DNases, Ligases, and RNA Polymerases are key enzymes involved in nucleic acid metabolism, with DNases involved in DNA degradation, Ligases in DNA and RNA joining, and RNA Polymerases in RNA synthesis from DNA templates. They play critical roles in various cellular processes, molecular biology techniques, and biomedical applications. It has diverse applications in various science, research, and industry fields. They are fundamental tools in molecular biology research for studying DNA and RNA. They are used in techniques such as PCR (Polymerase Chain Reaction), DNA cloning, DNA sequencing, and gene expression analysis. Researchers employ these enzymes to investigate gene function, regulation, and interaction, advancing our understanding of biological processes.

Furthermore, it plays crucial roles in manipulating DNA molecules in genetic engineering. Ligases join DNA fragments with complementary ends, facilitating DNA cloning, gene insertion, and recombinant DNA technology. RNA Polymerases transcribe DNA into RNA, allowing scientists to generate RNA molecules for various applications, including gene expression studies and RNA interference experiments.

With a higher prevalence of cancer cases in Mexico, there is an augmented need for research into the molecular mechanisms underlying cancer development, progression, and response to treatment. As per the All. Can, cancer is the third leading cause of death in Mexico. Over 195,000 new cases were registered in 2020. Breast (29.929), prostate (26.742), thyroid (11,227), colon (11,191), and cervical cancer (9,439) were among those with the highest prevalence. In that same year, the number of deaths in the country reached 90,222 cases. DNases, Ligases, and RNA Polymerases are essential tools in cancer research laboratories for various applications, including gene expression analysis, mutation detection, epigenetic studies, and biomarker discovery. The rise in cancer cases drives the demand for novel cancer therapeutics, including targeted therapies, immunotherapies, and gene-based treatments. Thus, expansion of the pharmaceutical industry and high prevalence of caner in the region is driving the growth of the market.

Based on DNases Application, the market is segmented into Biopharmaceutical Processing and Others. Based on Ligases Application, the market is segmented into Oligonucleotide Synthesis and Others. Based on RNA Polymerases Application, the market is segmented into mRNA Production and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Promega Corporation
  • Raybiotech Life, Inc.
  • Qiagen N.V
  • Abnova Corporation
  • Takara Bio Inc. (Takara Holdings Inc.)
  • BPS Bioscience, Inc.
  • New England Biolabs, Inc.
North America DNases, Ligases, And RNA Polymerases Market Report Segmentation

By DNases Application
  • Biopharmaceutical Processing
  • Others
By Ligases Application
  • Oligonucleotide Synthesis
  • Others
By RNA Polymerases Application
  • mRNA Production
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America DNases, Ligases, And RNA Polymerases Market, by DNases Application
1.4.2 North America DNases, Ligases, And RNA Polymerases Market, by Ligases Application
1.4.3 North America DNases, Ligases, And RNA Polymerases Market, by RNA Polymerases Application
1.4.4 North America DNases, Ligases, And RNA Polymerases Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4 Porter Five Forces Analysis
Chapter 5. North America DNases, Ligases, And RNA Polymerases Market by DNases Application
5.1 North America Biopharmaceutical Processing Market by Region
5.2 North America Others Market by Region
Chapter 6. North America DNases, Ligases, And RNA Polymerases Market by Ligases Application
6.1 North America Oligonucleotide Synthesis Market by Country
6.2 North America Others Market by Country
Chapter 7. North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
7.1 North America mRNA Production Market by Country
7.2 North America Others Market by Country
Chapter 8. North America DNases, Ligases, And RNA Polymerases Market by Country
8.1 US DNases, Ligases, And RNA Polymerases Market
8.1.1 US DNases, Ligases, And RNA Polymerases Market by DNases Application
8.1.2 US DNases, Ligases, And RNA Polymerases Market by Ligases Application
8.1.3 US DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
8.2 Canada DNases, Ligases, And RNA Polymerases Market
8.2.1 Canada DNases, Ligases, And RNA Polymerases Market by DNases Application
8.2.2 Canada DNases, Ligases, And RNA Polymerases Market by Ligases Application
8.2.3 Canada DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
8.3 Mexico DNases, Ligases, And RNA Polymerases Market
8.3.1 Mexico DNases, Ligases, And RNA Polymerases Market by DNases Application
8.3.2 Mexico DNases, Ligases, And RNA Polymerases Market by Ligases Application
8.3.3 Mexico DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
8.4 Rest of North America DNases, Ligases, And RNA Polymerases Market
8.4.1 Rest of North America DNases, Ligases, And RNA Polymerases Market by DNases Application
8.4.2 Rest of North America DNases, Ligases, And RNA Polymerases Market by Ligases Application
8.4.3 Rest of North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Merck KGaA
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Promega Corporation
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Product Launches and Product Expansions:
9.4.2.2 Geographical Expansions:
9.4.3 SWOT Analysis
9.5 RayBiotech Life, Inc.
9.5.1 Company Overview
9.5.2 SWOT Analysis
9.6 Qiagen N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.6 SWOT Analysis
9.7 Abnova Corporation
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.7.3 SWOT Analysis
9.8 Takara Bio Inc. (Takara Holdings Inc.)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.9 BPS Bioscience, Inc.
9.9.1 Company Overview
9.10. New England Biolabs, Inc.
9.10.1 Company Overview
9.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings